Published in Prostate on October 01, 1994
Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling. Dis Model Mech (2009) 1.31
Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling. Proc Natl Acad Sci U S A (2005) 1.21
Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation (1995) 5.06
Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med (1979) 2.82
Consensus criteria for traumatic grief. A preliminary empirical test. Br J Psychiatry (1999) 2.75
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res (1993) 1.96
Spread of prostatic cancer to bone. Urology (1983) 1.94
Seizures associated with antidepressants: a review. J Clin Psychiatry (1993) 1.91
Caspase control: protagonists of cancer cell apoptosis. Exp Oncol (2012) 1.69
Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci U S A (1991) 1.63
Suramin, an active drug for prostate cancer: interim observations in a phase I trial. J Natl Cancer Inst (1993) 1.54
Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol (1977) 1.53
Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Clin Cancer Res (1997) 1.44
The use of bladder for total transplant ureteral reconstruction. J Urol (1998) 1.40
Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol (1996) 1.39
Influence of traumatic grief on suicidal ideation among young adults. Am J Psychiatry (1999) 1.38
Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res (2001) 1.35
Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J Urol (1996) 1.30
Perspectives on care at the close of life. Caring for bereaved patients: "all the doctors just suddenly go". JAMA (2001) 1.30
bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology (1998) 1.29
Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells. Oncogene (1993) 1.29
Quality of life impairments associated with diagnostic criteria for traumatic grief. Psychol Med (2000) 1.28
Androgen regulation of programmed death of normal and malignant prostatic cells. J Androl (1993) 1.28
Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol (1996) 1.27
Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha induction. Br J Cancer (2003) 1.25
Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target. Cell Tissue Res (2000) 1.23
Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Cell Growth Differ (1998) 1.22
Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations. Cancer Res (1998) 1.19
Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Cancer Res (1999) 1.18
Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1. Cancer Chemother Pharmacol (2001) 1.17
The detrimental effect of poor early graft function after laparoscopic live donor nephrectomy on graft outcomes. Am J Transplant (2008) 1.17
Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol (1997) 1.16
Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J Urol (1999) 1.16
The measurement of grief: bereaved versus non-bereaved. Hosp J (1986) 1.15
Adverse life events and cognitive-personality characteristics in the prediction of major depression and antidepressant response. Am J Psychiatry (2000) 1.15
Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemother Pharmacol (1999) 1.14
Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esterase. Cancer Res (2000) 1.12
Programmed death of nonproliferating androgen-independent prostatic cancer cells. Cancer Res (1991) 1.12
Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression. Int J Cancer (1996) 1.12
Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate (1989) 1.11
The influence of marital quality and attachment styles on traumatic grief and depressive symptoms. J Nerv Ment Dis (1998) 1.09
Retrograde method for percutaneous access to kidney. Urology (1983) 1.09
Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells. Endocrinology (1990) 1.07
Enhanced prostaglandin synthesis after ultraviolet injury is mediated by endogenous histamine stimulation. A mechanism for irradiation erythema. J Clin Invest (1990) 1.06
Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol (1999) 1.04
Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer. Int J Cancer (1997) 1.04
Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia. J Urol (1998) 1.03
Lymphocyte transformation abnormalities in bovine immunodeficiency-like virus infected calves. Immunol Lett (1991) 1.03
Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum. J Med Chem (1999) 1.03
The efficacy of relaxation response interventions with adult patients: a review of the literature. J Cardiovasc Nurs (1996) 1.02
A diagnostic in vitro urine assay for interstitial cystitis. Urology (1998) 1.02
Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy. Antimicrob Agents Chemother (1994) 1.00
Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis (2002) 0.99
Nuclear and nucleolar localization of an African swine fever virus protein, I14L, that is similar to the herpes simplex virus-encoded virulence factor ICP34.5. J Gen Virol (1999) 0.98
Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent. Cancer Chemother Pharmacol (1999) 0.97
Amino-terminal sequence of a large form of basic fibroblast growth factor isolated from human benign prostatic hyperplastic tissue. Biochem Biophys Res Commun (1987) 0.97
Laparoscopic nephrectomy in the markedly obese living renal donor. Urology (2000) 0.96
Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin. Prostate (2001) 0.95
Helical computerized tomography arteriography for evaluation of live renal donors undergoing laparoscopic nephrectomy. J Urol (1999) 0.94
Prostatic osteoblastic factor. Invest Urol (1979) 0.94
Ureteral injury due to blunt and penetrating trauma. Urology (1992) 0.93
Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia. Prostate (2001) 0.93
African swine fever virus gene j13L encodes a 25-27 kDa virion protein with variable numbers of amino acid repeats. J Gen Virol (1995) 0.93
The cost value of medical versus surgical hormonal therapy for metastatic prostate cancer. J Urol (2000) 0.93
Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate cancer (review). Oncol Rep (2000) 0.92
Apoptosis and bcl-2 expression in prostate cancer: significance in clinical outcome after brachytherapy. J Urol (2001) 0.92
Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells. Endocrinology (2001) 0.92
Primary signet-ring cell carcinoma of the urinary bladder. Cancer (1984) 0.92
Pathologic effects of pre-cystectomy therapy with combination intra-arterial doxorubicin hydrochloride and local bladder hyperthermia for bladder cancer. J Urol (1982) 0.92
The effects of cognitive impairment on 9-year mortality in a community sample. J Gerontol B Psychol Sci Soc Sci (1995) 0.90
Glyoxalase I inhibitors in cancer chemotherapy. Biochem Soc Trans (2003) 0.90
Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen: long-term followup. J Urol (1998) 0.90
Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients. Prostate (2000) 0.89
Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I. Cancer Chemother Pharmacol (2000) 0.88
Warm ischemia time does not correlate with recipient graft function in laparoscopic donor nephrectomy. Surg Endosc (2003) 0.88
Primary renal carcinoid tumor. Urology (1988) 0.88
Human immunodeficiency virus-1 Tat protein up-regulates interleukin-6 and interleukin-8 expression in human breast cancer cells. Inflamm Res (2005) 0.87
Congenital renal arteriovenous malformations. Urology (1981) 0.87
Influence of maternal grooming, sex and age on Fos immunoreactivity in the preoptic area of neonatal rats: implications for sexual differentiation. Dev Neurosci (1997) 0.87
Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT. Oncogene (2008) 0.86
Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina. Urology (1998) 0.86
Bereavement and catecholamines. J Psychosom Res (1986) 0.86
Recent life events in schizophrenia and depression. Psychol Med (1974) 0.85
Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death. Prostate (1994) 0.85
Cultured human prostate-derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from basic fibroblast growth factor. Prostate (1989) 0.85
Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis. J Urol (1993) 0.85
Late invasive recurrence despite long-term surveillance for superficial bladder cancer. J Urol (1993) 0.85
Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection. Cancer Res (1990) 0.85
Bilateral nephrectomy with concomitant renal graft transplantation for autosomal dominant polycystic kidney disease. J Urol (2000) 0.85
Sex differences in prolactin change during mourning. J Psychosom Res (1987) 0.85
Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats. Cancer Chemother Pharmacol (2001) 0.85